Synaptiq converts 1M RON loan into equity for AI radiotherapy software

What's the deal? Synaptiq, a Cluj-Napoca startup building AI-based medical software for radiotherapy, converted a 1,000,000 RON (about $218,088) loan from Constanța-based Expert CompanyDealroom has a profile for this one. Try Dealroom → - S.R.L. into a 3.21% equity stake. The move followed a shareholder decision on February 9, 2026, published in Romania's Official Gazette.

How it works: Expert Company had extended the loan on June 3, 2024, with an option to convert into equity. It exercised that option on January 8, 2026, after the December 8, 2025 maturity date passed.

The mechanics: The conversion raised Synaptiq's share capital from 1,505 to 1,555 RON through 50 new shares. Only 50 RON increased the nominal capital; the remaining 1,000,000 RON counts as a share premium held in reserves.

Why now? The loan converted just after its maturity lapsed, formalising an investor's stake that had been sitting as debt for roughly 18 months. At the time it was granted, the sum was equivalent to €201,000.

What's the endgame? Synaptiq develops software that applies artificial intelligence to radiotherapy, part of a broader push to bring machine learning into cancer treatment planning.

The signal: The conversion is a quick re-raise for Synaptiq, which had previously secured backing from GapMinderDealroom has a profile for this one. Try Dealroom →, CleverageDealroom has a profile for this one. Try Dealroom →, FortechDealroom has a profile for this one. Try Dealroom →, and SeedBlinkDealroom has a profile for this one. Try Dealroom →, and closed a €665,500 round that came in above target. Turning debt into equity lets a Romanian medtech extend its runway without a fresh cash round — a pragmatic path for startups tapping local investor capital.

Read more: Ziarul Financiar

Image credit: IAEA Imagebank